Research questions that span multiple complementary biological pathways benefit from the four-pathway framework
The dosing frequency depends on the specific medication
It represents the most common cause of long-term disability, the second leading cause of dementia, and the fourth leading cause of mortality in developed countries (Sveinsson et al., 2014)
In support of these findings, a meta-analysis published in 2025 confirmed the efficacy and superiority of intermittent fasting (IF) over control conditions not only in reducing fasting glucose levels, HbA1c, and body weight, but also in improving body mass index (BMI), waist circumference, systolic and diastolic blood pressure, low-density lipoprotein (LDL) cholesterol, and total cholesterol
It earned FDA approval, generated billions in revenue, and became the most talked-about weight management compound in modern history